Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-year Follow-up



Moderna and Merck said on Tuesday their experimental personalized vaccine continued to ‌cut the risk of death or recurrence of the most deadly skin cancer five years after…
Reuters Health Information



Source link : https://www.medscape.com/s/viewarticle/moderna-mercks-skin-cancer-vaccine-shows-sustained-benefit-2026a10001vf?src=rss

Author :

Publish date : 2026-01-20 11:24:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version